Skip to main content

Table 1 Characteristics of study participants by sex and age

From: Confounding influences of malnutrition and Plasmodium falciparum and Schistosoma haematobium infections on haematological parameters in school children in Muyuka, Cameroon

Parameter

Sex

Age group in years

Overall

P- value

Female

Male

P-value

4–9

10–14

% (N)

50.8 (308)

49.2 (298)

 

59.1 (358)

40.9 (248)

100 (606)

 

Mean age (SD) in years

8.97 (2.0)

8.91 (2.3)

0.724

7.50 (1.4)

11.0 (1.1)

8.94 (2.1)

< 0.001

Mean height (SD) in cm

126.6 (12.3)

123.7 (12.3)

0.004

118.7 (10.1)

134.5 (9.0)

125.2 (12.4)

< 0.001

Mean weight (SD) in kg

28.2 (7.0)

27.6 (9.3)

0.431

24.4 (4.7)

33.1 (9.3)

27.9 (8.2)

< 0.001

Site % (n)

Bafia

18.2 (56)

14.4 (43)

 

14.2 (51)

19.4 (45)

16.3 (99)

 

Ikata

25.3 (78)

23.5 (70)

0.315

24.3 (87)

24.6 (61)

24.4 (148)

0.216

Likoko

56.5 (174)

62.1 (185)

 

61.5 (220)

56.0 (139)

59.2 (359)

 
  

Clinical profile

   

Fever prevalence (n)

20.1 (61)

23.6 (69)

0.292

22.1 (77)

21.4 (53)

21.8 (130)

0.826

Anaemia prevalence (n)

74.0 (228)

74.8 (223)

0.820

78.5 (281)

68.5 (170)

74.4 (451)

0.006

Malaria parasite prevalence (n)

25.6 (79)

23.2 (69)

0.475

24.9 (89)

23.8 (59)

24.4 (148)

0.73

Asymptomatic malaria prevalence (n)

20.8 (64)

17.8 (53)

0.351

19.8 (71)

18.5 (46)

19.3 (117)

0.694

UGS prevalence (n)

28.6 (88)

20.5 (61)

0.021

23.5 (84)

26.2 (65)

24.6 (149)

0.440

Haematuria prevalence (n)

14.9 (46)

9.4 (28)

0.037

11.2 (40)

13.7 (34)

12.2 (74)

0.348

aUnderweight prevalence (n)

4.3 (10)

8.9 (20)

0.044

5.3 (19)

11.0 (11)

6.6 (30)

0.042

Stunting prevalence (n)

16.9 (52)

29.2 (87)

< 0.001

17.9 (64)

30.2 (75)

22.9 (139)

< 0.001

bWasting prevalence (n)

9.1 (1)

4.5 (1)

0.606

6.1 (2)

 

6.1 (2)

 

Malnutrition prevalence (n)

19.2 (59)

32.9 (98)

< 0.001

21.2 (76)

32.7 (81)

25.9 (157)

0.002

Leucopenia prevalence (n)

1.9 (6)

2.0 (6)

0.954

2.0 (7)

2.0 (5)

2.0 (12)

0.958

Microcytosis prevalence (n)

40.3 (124)

50.7 (298)

0.010

51.7 (185)

36.3 (90)

45.4 (275)

< 0.001

Thrombocytopaenia prevalence (n)

11.0 (34)

11.1 (33)

0.989

13.4 (48)

7.7 (19)

11.1 (67)

0.027

  1. aUnderweight was evaluated for 458 SAC
  2. bWasting was evaluated for 33 SAC
  3. P-values in bold are statistically significant.